PHASE II STUDY OF IFOSFAMIDE, CARBOPLATIN, AND ETOPOSIDE IN PATIENTS WITH A FIRST RECURRENCE OF GLIOBLASTOMA MULTIFORME

被引：0
|
作者：
Aoki, T. [1 ]
Ueba, T. [3 ]
Takahashi, J. [1 ]
Miyatake, S. [2 ]
Nozaki, K. [4 ]
Taki, W. [5 ]
Matsutani, M. [6 ]
机构：
[1] Kitano Hosp, Brain Tumor Ctr, Osaka, Japan
[2] Osaka Med Coll, Takatsuki, Osaka 569, Japan
[3] Kishiwada City Hosp, Kishiwada, Japan
[4] Shiga Univ Med Sci, Otsu, Shiga 52021, Japan
[5] Mie Univ, Tsu, Mie 514, Japan
[6] Saitama Med Univ, Int Med Ctr, Saitama, Japan
来源：
NEURO-ONCOLOGY | 2010年 / 12卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：48 / 48
页数：1
相关论文
共 50 条
  • [31] Temozolomide and concurrent radiotherapy in patients with glioblastoma multiforme -: First results of a phase II trial
    Micke, O
    Schäfer, U
    Schüller, P
    Schul, C
    Willich, N
    STRAHLENTHERAPIE UND ONKOLOGIE, 2004, 180 : 36 - 36
  • [32] Radiotherapy and concomitant weekly carboplatin and daily etoposide for patients with inoperable biopsy proven glioblastoma multiforme.
    Simon, JM
    Noel, G
    Hoang-Xuan, K
    Carpentier, AF
    Mokhtari, K
    Racadot, S
    Baillet, F
    Mazeron, JJ
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 118S - 118S
  • [33] A phase II study of filgrastim-mobilized peripheral blood progenitor cell infusion support for pediatric patients treated with ifosfamide, carboplatin and etoposide
    Anderson, RA
    Corr, TR
    Schultz, KR
    Hewitt, LA
    Davis, JH
    Fryer, CJH
    BLOOD, 1995, 86 (10) : 1600 - 1600
  • [34] PHASE-II TRIAL OF ETOPOSIDE, CARBOPLATIN, AND IFOSFAMIDE AS SALVAGE THERAPY IN ADVANCED OVARIAN-CARCINOMA
    BEDDOE, AM
    DOTTINO, PR
    COHEN, CJ
    MOUNT SINAI JOURNAL OF MEDICINE, 1993, 60 (04): : 311 - 316
  • [35] Treatment of newly diagnosed glioblastoma multiforme with carmustine, cisplatin and etoposide followed by radiotherapy. A phase II study
    Lassen, U
    Kristjansen, PEG
    Wagner, A
    Kostel-janetz, M
    Poulsen, HS
    JOURNAL OF NEURO-ONCOLOGY, 1999, 43 (02) : 161 - 166
  • [36] Treatment of newly diagnosed glioblastoma multiforme with carmustine, cisplatin and etoposide followed by radiotherapy. A phase II study
    Ulrik Lassen
    Paul E.G. Kristjansen
    Aase Wagner
    Michael Kosteljanetz
    Hans Skovgaard Poulsen
    Journal of Neuro-Oncology, 2003, 62 : 362 - 362
  • [37] Final results of brentuximab vedotin combined with ifosfamide-carboplatin-etoposide in first refractory/relapsed Hodgkin lymphoma: a lymphoma study association phase I/II study
    Stamatoullas, Aspasia
    Ghesquieres, Herve
    Feugier, Pierre
    Andre, Marc
    Le Bras, Fabien
    Gac, Anne-Claire
    Borel, Cecile
    Gastinne, Thomas
    Quittet, Philippe
    Morschhauser, Franck
    Ribrag, Vincent
    Guidez, Stephanie
    Nicolas-Virelizier, Emmanuelle
    Berriolo-Riedinger, Alina
    Vander Borght, Thierry
    Edeline, Veronique
    Brice, Pauline
    LEUKEMIA & LYMPHOMA, 2022, 63 (13) : 3063 - 3071
  • [38] Treatment of Newly Diagnosed Glioblastoma Multiforme with Carmustine, Cisplatin and Etoposide Followed by Radiotherapy. A Phase II Study
    Ulrik Lassen
    Paul E.G. Kristjansen
    Aase Wagner
    Michael Kostel-janetz
    Hans Skovgaard Poulsen
    Journal of Neuro-Oncology, 1999, 43 : 161 - 166
  • [39] PHASE-II STUDY OF CARBOPLATIN AND ETOPOSIDE AS A FIRST-LINE REGIMEN IN PATIENTS WITH METASTATIC BREAST-CANCER
    VANDERGAAST, A
    BONTENBAL, M
    PLANTING, AST
    KOK, TC
    SPLINTER, TAW
    ANNALS OF ONCOLOGY, 1994, 5 (09) : 858 - 860
  • [40] Phase II study of CCI-779 in patients with recurrent glioblastoma multiforme
    Chang, SM
    Wen, P
    Cloughesy, T
    Greenberg, H
    Schiff, D
    Conrad, C
    Fink, K
    Robins, HI
    De Angelis, L
    Raizer, J
    Hess, K
    Aldape, K
    Lamborn, KR
    Kuhn, J
    Dancey, J
    Prados, MD
    INVESTIGATIONAL NEW DRUGS, 2005, 23 (04) : 357 - 361
12345